Showing results (81-90 of 496) with videos related to
Sort By:
Pageof 50
Neuropharmacology|August 1, 1985
Comparison of benzodiazepine receptor binding in membranes from human or rat brainW Sieghart, A Eichinger, P Riederer, et al.European Archives of Psychiatry and Clinical Neuroscience|February 2, 2000
Investigations on oxidative stress and therapeutical implications in dementiaN Durany, G Münch, T Michel, et al.European Neurology|January 1, 1991
Iron in brain function and dysfunction with emphasis on Parkinson's diseaseM B Youdim, D Ben-Shachar, P RiedererJournal of Neural Transmission|January 1, 1979
Effects of post-mortem storage on synaptic 5-HT binding and uptake in mammalian brainN Weiner, C Martin, W Wesemann, et al.Journal of Neural Transmission. Supplementum|April 24, 2007
Apoptosis inhibition in T cells triggers the expression of proinflammatory cytokines--implications for the CNSC Scheller, P Riederer, M Gerlach, et al.Wiener Klinische Wochenschrift|May 11, 1979
[The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)]F Podiwinsky, M Mentasti, P Riederer, et al.Journal of Neural Transmission. Supplementum|January 1, 1990
The role of monoamine oxidase, iron-melanin interaction, and intracellular calcium in Parkinson's diseaseM B Youdim, D Ben-Shachar, P RiedererJournal of Neural Transmission|January 1, 1977
Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndromeP Riederer, W Birkmayer, D Seemann, et al.Neurochemical Research|December 1, 1993
Effects of long-term recovery from transient cerebral ischemia in rat brain: tissue levels of acetylcholine, monoamines, and their metabolitesL Frölich, A Dirr, P Riederer, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1993
The possible role of iron in the etiopathology of Parkinson's diseaseM B Youdim, D Ben-Shachar, P RiedererPageof 50